With a truly patient-focussed approach we offer a best-in-class Early Access Program service that ensures patient, healthcare professional, and client needs are met through passionate and tailored program delivery.
Sourcing commercial drug products for clinical trials can be a complex process and is often one of the last considerations during study design. Our experienced Global Sourcing Team is uniquely positioned to support you through the commercial drug sourcing process with their deep understanding of clinical trials and commercial drug markets.
With a truly patient-focused approach, we offer a best-in-class Early Access Program service that ensures patient, healthcare professional, and client needs are met through passionate and tailored program delivery.
Our Early Access Programs (often called Expanded Access, Pre-approval Access, Compassionate Use, Named Patient or Managed Access Programs) deliver potentially life-saving treatments to patients around the world while adding true value to our clients through a range of additional cutting-edge services.
Patients are at the heart of everything we do. Our vision is to help current and future generations by providing timely and appropriate treatment access to patients in desperate need.
We provide in-house, highly specialized and EAP centric clinical services, including dedicated Real-World Evidence, Pharmacovigilance and Medical teams to support all program requirements. Our vast experience in oncology and rare disease, and dedicated EAP teams and processes, are essential to providing innovative EAP solutions to pharma and biotech companies globally.
Facing a high unmet need and a history of challenges around early access to treatments.
Rescue of a global oncology EAP on behalf of a large pharmaceutical company.
Rapid set-up of EAP for a rare oncology product.
Discover more about the services and capabilities Bionical Emas has to offer
